Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification
John Amara, Ph.D. and Michael Dullen Merck, 80 Ashby Road, Bedford, MA, 01730, USA
Changing Column Packing from an Art into a Science
Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
View All Featured ArticlesHeadline News
FDA clears expanded ENT indication for Johnson & Johnson’s HARMONIC 1100 Shears
Abbott begins VOYAGER trial of investigational Encantor TAVI system
AbbVie invests $217m to modernise Puerto Rico biologics manufacturing campus
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
BPOG Risk Based Approaches to Use of Closed Systems in Renovations of Existing Biopharma API Facilities
Presented by Lars Hovmand-Lyster, Senior Engineering specialist in Novo Nordisk Global Project Office (GPO) Engineering management department and Ernest Jenness, Senior Product Manager for Mobius Single-Use Products at Merck
05th March 2019
Mapping Future Technology Needs For Real Time Release Testing
Presented by Dr Udayanath Aich, Associate Director at Bristol-Myers Squibb
09th August 2019
Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins
Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca & Piet Christieans, PhD, Scientific Director at Nelson Lab
14th May 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Best Practices for Achieving Virus Safety
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















